Literature DB >> 25878340

Fecal microbiota transplantation and successful resolution of multidrug-resistant-organism colonization.

Nancy F Crum-Cianflone1, Eva Sullivan2, Gonzalo Ballon-Landa3.   

Abstract

We report a case in which fecal microbiota transplantation (FMT) utilized for relapsing Clostridium difficile colitis successfully eradicated colonization with several multidrug-resistant organisms (MDROs). FMT may have an additive benefit of reducing MDRO carriage and should be further investigated as a potential measure to eradicate additional potentially virulent organisms beyond C. difficile.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Year:  2015        PMID： 25878340      PMCID： PMC4432040          DOI： 10.1128/JCM.00820-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

Review 1.  Mutation frequencies and antibiotic resistance.

Authors:  J L Martinez; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

2.  Donor feces infusion for eradication of Extended Spectrum beta-Lactamase producing Escherichia coli in a patient with end stage renal disease.

Authors:  R Singh; E van Nood; M Nieuwdorp; B van Dam; I J M ten Berge; S E Geerlings; F J Bemelman
Journal:  Clin Microbiol Infect       Date:  2014-07-08       Impact factor: 8.067

Review 3.  The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection.

Authors:  R Singh; M Nieuwdorp; I J M ten Berge; F J Bemelman; S E Geerlings
Journal:  Clin Microbiol Infect       Date:  2014-11-07       Impact factor: 8.067

Review 4.  Selection and evolution of resistance to antimicrobial drugs.

Authors:  Diarmaid Hughes
Journal:  IUBMB Life       Date:  2014-06-16       Impact factor: 3.885

5.  Interplay between plasmid-mediated and chromosomal-mediated fluoroquinolone resistance and bacterial fitness in Escherichia coli.

Authors:  Jesús Machuca; Alejandra Briales; Gema Labrador; Paula Díaz-de-Alba; Rafael López-Rojas; Fernando Docobo-Pérez; Luis Martínez-Martínez; Jesús Rodríguez-Baño; Maria Eugenia Pachón; Alvaro Pascual; José-Manuel Rodríguez-Martínez
Journal:  J Antimicrob Chemother       Date:  2014-08-19       Impact factor: 5.790

6.  Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection.

Authors:  Ilan Youngster; George H Russell; Christina Pindar; Tomer Ziv-Baran; Jenny Sauk; Elizabeth L Hohmann
Journal:  JAMA       Date:  2014-11-05       Impact factor: 56.272

Review 7.  Microbiota-mediated colonization resistance against intestinal pathogens.

Authors:  Charlie G Buffie; Eric G Pamer
Journal:  Nat Rev Immunol       Date:  2013-10-07       Impact factor: 53.106

Review 8.  Control of pathogens and pathobionts by the gut microbiota.

Authors:  Nobuhiko Kamada; Grace Y Chen; Naohiro Inohara; Gabriel Núñez
Journal:  Nat Immunol       Date:  2013-07       Impact factor: 25.606

9.  Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa.

Authors:  Eva Sullivan; Joyce Bensman; Mimi Lou; Melissa Agnello; Kimberly Shriner; Annie Wong-Beringer
Journal:  Crit Care Med       Date:  2014-01       Impact factor: 7.598

Review 10.  Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis.

Authors:  Zain Kassam; Christine H Lee; Yuhong Yuan; Richard H Hunt
Journal:  Am J Gastroenterol       Date:  2013-03-19       Impact factor: 10.864
View more
  40 in total

1.  Predominance of Lactobacillus spp. Among Patients Who Do Not Acquire Multidrug-Resistant Organisms.

Authors:  Rafael Araos; Albert K Tai; Graham M Snyder; Martin J Blaser; Erika M C D'Agata
Journal:  Clin Infect Dis       Date:  2016-06-28       Impact factor: 9.079

2.  Efficacy and safety of fecal microbiota transplantation for decolonization of intestinal multidrug-resistant microorganism carriage: beyond Clostridioides difficile infection.

Authors:  Young Kyung Yoon; Jin Woong Suh; Eun-Ji Kang; Jeong Yeon Kim
Journal:  Ann Med       Date:  2019-09-13       Impact factor: 4.709

Review 3.  Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature.

Authors:  Nathaniel Aviv Cohen; Nitsan Maharshak
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

Review 4.  THE POWER OF POOP: FECAL MICROBIOTA TRANSPLANTATION FOR CLOSTRIDIUM DIFFICILE INFECTION.

Authors:  Michael B Edmond
Journal:  Trans Am Clin Climatol Assoc       Date:  2016

5.  Editorial Commentary: Fecal ESBL Screening: Are We Ready for This Information?

Authors:  Sarah E Turbett; Michael K Mansour
Journal:  Clin Infect Dis       Date:  2016-05-03       Impact factor: 9.079

Review 6.  Carbapenem-Resistant Enterobacteriaceae in Solid Organ Transplantation: Management Principles.

Authors:  Olivia Smibert; Michael J Satlin; Anoma Nellore; Anton Y Peleg
Journal:  Curr Infect Dis Rep       Date:  2019-06-10       Impact factor: 3.725

Review 7.  The Epidemiology, Evolution, and Treatment of KPC-Producing Organisms.

Authors:  Ann Marie Porreca; Kaede V Sullivan; Jason C Gallagher
Journal:  Curr Infect Dis Rep       Date:  2018-05-05       Impact factor: 3.725

Review 8.  Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection.

Authors:  Brendan J Kelly; Pablo Tebas
Journal:  Chest       Date:  2017-09-18       Impact factor: 9.410

Review 9.  Can Consideration of the Microbiome Improve Antimicrobial Utilization and Treatment Outcomes in the Oncology Patient?

Authors:  Jessica R Galloway-Peña; Robert R Jenq; Samuel A Shelburne
Journal:  Clin Cancer Res       Date:  2017-03-15       Impact factor: 12.531

10.  Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial.

Authors:  Jasmohan S Bajaj; Zain Kassam; Andrew Fagan; Edith A Gavis; Eric Liu; I Jane Cox; Raffi Kheradman; Douglas Heuman; Jessica Wang; Thomas Gurry; Roger Williams; Masoumeh Sikaroodi; Michael Fuchs; Eric Alm; Binu John; Leroy R Thacker; Antonio Riva; Mark Smith; Simon D Taylor-Robinson; Patrick M Gillevet
Journal:  Hepatology       Date:  2017-10-30       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.